Antihypertensive drug utilization and blood pressure outcomes in chronic kidney disease patients: A prospective observational study in a tertiary care hospital
摘要
Hypertension is highly prevalent in chronic kidney disease (CKD) and contributes to cardiovascular complications and progressive renal dysfunction. Evaluating real-world antihypertensive prescribing patterns may help optimize blood pressure management in this high-risk population.
MethodsA six-month prospective observational study was conducted among 100 adults with CKD and hypertension attending a tertiary-care teaching hospital. Demographic characteristics, CKD stage, associated clinical conditions, antihypertensive prescriptions, blood pressure, and serum creatinine were recorded at baseline and follow-up. Changes in clinical parameters were analyzed using paired Student's t-test.
ResultsThe study population comprised 64% males, with most patients aged 41–70 years. Advanced CKD predominated, with 53% and 19% classified as Stage 5 and Stage 4, respectively. Diabetes mellitus (36%) was the most frequent associated condition. Among 198 antihypertensive prescriptions, diuretics (37.8%) and calcium channel blockers (29.0%) were the most commonly prescribed drug classes. Significant reductions were observed in systolic blood pressure (160.13±25.26 to 134.20±19.77 mmHg), diastolic blood pressure (92.63±13.07 to 80.10±10.94 mmHg), and serum creatinine (5.59±3.73 to 4.04±3.20 mg/dL) (all p<0.001).
ConclusionsAntihypertensive prescribing was largely influenced by advanced CKD, with diuretics and calcium channel blockers predominating. Blood pressure and serum creatinine improved during follow-up; however, these observational findings should not be interpreted as evidence of treatment efficacy. Further multicenter studies with longer follow-up are warranted.
Graphical Abstract